Maclowin Lifescience Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-07-2024
- Paid Up Capital ₹ 0.10 M
as on 16-07-2024
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 4.00 M
as on 16-07-2024
- Revenue -2.83%
(FY 2023)
- Profit -23.33%
(FY 2023)
- Ebitda 215.94%
(FY 2023)
- Net Worth 42.41%
(FY 2023)
- Total Assets 25.77%
(FY 2023)
About Maclowin Lifescience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹4.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Prashant Murarka, Suresh Murarka, Himanshu Murarka, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24230RJ2016PTC055044
- Company No.
055044
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 May 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Maclowin Lifescience Private Limited offer?
Maclowin Lifescience Private Limited offers a wide range of products and services, including Respiratory System Drugs, Anti Asthma Drug, Digestive System Drugs & Medicines, Antacid Drugs, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Anti Infective Drugs & Medicines, Anti Allergic Drug, Common Disease Medicines, Anti Smoking Drugs.
Who are the key members and board of directors at Maclowin Lifescience?
Board Members(5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Prashant Murarka | Director | 10-Dec-2019 | Current |
Suresh Murarka | Director | 21-Mar-2022 | Current |
Himanshu Murarka | Director | 25-May-2016 | Current |
Kapil Murarka | Director | 10-Dec-2019 | Current |
Shubham Gadia | Director | 21-Sep-2022 | Current |
Financial Performance and Corporate Structure Insights of Maclowin Lifescience.
Maclowin Lifescience Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.83% decrease. The company also saw a substantial fall in profitability, with a 23.33% decrease in profit. The company's net worth Soared by an impressive increase of 42.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Maclowin Lifescience?
In 2023, Maclowin Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shree Mangal Murti Buildmat Private Limited
Active 10 years 14 daysPrashant Murarka is a mutual person
Ambujam Metal Works Private Limited
Inactive For E-Filing 10 months 14 daysKapil Murarka is a mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 25 Feb 2022 | ₹4.00 M | Satisfied |
How Many Employees Work at Maclowin Lifescience?
Unlock and access historical data on people associated with Maclowin Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maclowin Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maclowin Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.